5th In-House Impact: Life Sciences Summit 2024

Welcome to the In-House Impact: Life Sciences Summit 2024, the premier event tailored exclusively for life sciences General Counsel and Chief Legal Officers to address industry-specific legal challenges. From strategizing for successful IPOs to fostering cross-functional collaboration, cultivating leadership accountability within teams, and championing DE AND I amidst funding constraints, this summit offers a unique platform for legal teams to exchange best practices and drive commercial influence within life sciences companies.

This summit is the only event dedicated to uniting in-house members to share exclusive insights and take part in imperative discussions on how legal teams can enact direct commercial influence in Life Sciences Companies. Join 60+ of your fellow GC’s, Chief Legal Officers, Risk Management, and Compliance experts from across leading pharma, biotech, medical device, and pharmaceutical services to successfully navigate developing compliance regulations, exchange strategies in task prioritization, and secure a seat at the table as a commercial leader.

URLs:
Website: https://go.evvnt.com/2329355-0?pid=176 
Tickets: https://go.evvnt.com/2329355-2?pid=176 
Brochure: https://go.evvnt.com/2329355-3?pid=176 

Time: 9:00 AM - 5:00 PM

Prices:
Conference + Networking Activity and Evening - Life Sciences In-House Legal Counsel: USD 2498.00,
Conference Only Pass - Life Sciences In-House Legal Counsel: USD 2299.00,
Conference Only - Standard Pricing: USD 3699.00

Speakers: Annie Mcguire Senior Vice President and General Counsel Veracyte, Brendan St. Amant General Counsel and Corporate Secretary Synlogic, Casarine Chong Senior Vice President, Associate General Counsel - Transactions Bristol Myers Squibb, Christo Siebrits Senior Associate General Counsel - Head of AI Abbvie, Edward Sturchio General Counsel and Corporate Secretary Immatics GmbH, Eric Rogers Vice President - Ethics and Compliance, Alexion RDU AstraZeneca, Erin Chance Assistant General Counsel and Chief Compliance Officer Vivex, Federico Vargiu Head of Legal and Compliance Menarini Group, Gregory Montalbano Associate Head of General Counsel and Compliance Assertio Therapeutics Inc., Gretchen Fritz Chief Legal Officer and Vice President American Regent - Inc, Holly Logue Associate General Counsel Gilead Sciences, Jean Frydman Vice President, Associate General Counsel, Corporate Compliance and Privacy Officer Aquestive Therapeutics, Joanna Wu General Counsel Ensem Therapeutics, Julia Lifshits Assistant General Counsel Beckman Coulter Inc., Kyle Crossley Head of Corporate Legal and Corporate Secretary Corium International Inc., Leticia Padilla De Truman Corporate Counsel Aveo Oncology, Peter Heinecke Chief Officer- Business and General Counsel Leapfrog Bio, Rahul Khara General Counsel Disc Medicine, Rupa Cornell Vice President and Head Counsel for Vaccine Business Unit Takeda Pharmaceutical Co. Ltd., Thomas Gnielinski VP Associate General Counsel Bridge Bioscience Corp